A T-cell-mediated immune response is initiated by the T-cell receptor (TCR) interacting with peptide-bound major histocompatibility complex (pMHC) on an infected cell. The mechanism by which this interaction triggers intracellular phosphorylation of the TCR, which lacks a kinase domain, remains poorly understood. Here, we have introduced the TCR and associated signalling molecules into a non-immune cell and reconstituted ligand-specific signalling when these cells are conjugated with antigen-presenting cells. We show that signalling requires the differential segregation of a phosphatase and kinase in the plasma membrane. An artificial, chemically controlled receptor system generates the same effect as TCR-pMHC, demonstrating that the binding energy of an extracellular protein-protein interaction can drive the spatial segregation of membrane proteins without a transmembrane conformational change. This general mechanism may extend to other receptors that rely on extrinsic kinases, including, as we demonstrate, chimaeric antigen receptors being developed for cancer immunotherapy.
In addition to intercellular communication mediated by soluble molecules, two cells can transmit signals through membraneassociated receptors and ligands. Adaptive immunity represents such a system, in which the MHC protein on the surface of antigenpresenting cells (APCs) interacts with the TCR on T lymphocytes. If the TCR binds pMHC of the right complementarity, the interaction results in tyrosine phosphorylation of the TCR (herein referred to as TCR 'triggering') and the initiation of signals that activate the T cell 1 . The TCR has no intrinsic kinase activity, unlike many other receptors 2 , and instead relies on a T-cell-specific kinase called Lck (ref. 3) . Also distinct from other systems, the phosphorylatable tyrosine residues of the TCR (the immunoreceptor tyrosine-based activation motifs (ITAMs)) 4 do not reside on the polypeptides that contact the pMHC (a, b) but instead are contained on tightly associated CD3 subunits (c, d, e 2 , f 2 ). The phosphorylated ITAMs then bind a second kinase, ZAP70, which is subsequently activated and drives downstream signalling 5 .
Despite considerable work, the mechanism by which pMHC binding leads to TCR triggering remains poorly understood (reviewed in ref. 6) . Some models propose that pMHC binding evokes a conformational change in the TCR that makes its cytoplasmic ITAM domains more accessible to Lck kinase 7 . Alternative triggering hypotheses include activation through the aggregation of TCR molecules 6 , and 'kinetic segregation' 8 , where TCR phosphorylation is favoured by its partitioning into plasma membrane domains that contain Lck kinase but are depleted of CD45 (also known as PTPRC), an abundant transmembrane phosphatase. However, although TCR clustering 9 and the segregation of CD45 away from the TCR have been observed 10 , it has not been established whether such events are necessary or sufficient for signal transduction across the plasma membrane. In addition, the physical basis of protein segregation within the plasma membrane is unclear.
Reconstitution of a biological phenomenon with defined components has proven to be a powerful means for dissecting molecular mechanisms. We have made use of this approach by introducing the genes encoding the TCR and other proteins required for regulating its phosphorylation into a non-immune cell and recapitulating TCR triggering when this cell forms a conjugate with an APC. Because each protein can be introduced separately and is genetically engineered, this system has allowed us to test models of TCR triggering and the roles of individual proteins in a manner that is difficult to achieve with native T cells.
Reconstitution of regulated TCR triggering
We first sought to reconstitute Lck-mediated TCR phosphorylation in a non-immune cell and then determine which factors are needed to keep the TCR quiescent ( Fig. 1a ). As the basis of our reconstitution, we expressed 11 the complete set of protein chains of the 1G4 TCR (ref. 12) in the plasma membrane of HEK cells (hereafter referred to as HEK-1G4) (Supplementary Methods and Supplementary Fig. 1 ). The expressed TCR complex did not show detectable phosphorylation (assayed by a phospho-specific antibody to the CD3f chain, an essential TCR subunit required for signalling 13, 14 ) unless Lck and ZAP70 were co-expressed ( Fig. 1b ). Lck kinase activity, as detected by measuring levels of activating (Tyr 394) and inhibitory (Tyr 505) phosphorylation 3 , seemed to be unaffected by the presence of the TCR or ZAP70 (Fig. 1b ). However, ZAP70 activity, as measured by increased Tyr 493 phosphorylation 5 , was only detectable in the presence of both Lck and the TCR (Fig. 1b ), which is in agreement with previous data suggesting that this kinase is inactive until it binds to phosphorylated CD3f ITAMs 15 (Fig. 1a ). We confirmed the activity of ZAP70 by demonstrating phosphorylation of co-expressed LAT, its downstream substrate and critical adaptor protein for T-cell signalling ( Supplementary Fig. 2a ).
To establish a quiescent system that could be activated by pMHC, we next sought to restrain the kinase activity of Lck. CSK induces an 'inactive' conformation of Lck by phosphorylating its carboxy terminus (Tyr 505) (ref. 16 ). However, co-expressing CSK and CSK-binding protein (CBP, also known as PAG1), which localizes CSK to the plasma membrane ( Fig. 1a) , was insufficient to repress Lck phosphorylation of CD3f ( Fig. 1c ). CD45 is a tyrosine phosphatase that modulates T-cell signalling in a complex manner by dephosphorylating the inhibitory Tyr 505 and activating Tyr 394 of Lck (refs 17, 18) and the ITAM tyrosines of the TCR (Fig. 1a ). Co-expression of CD45 with Lck severely diminished Lck-induced ZAP70 activation but only modestly inhibited phosphorylation of the CD3f chain of the TCR (Fig. 1c ). However, simultaneous expression of CSK, CBP and CD45 considerably reduced CD3f phosphorylation ( Fig. 1c ). This synergy depended on CBP ( Fig. 1c ), indicating that membrane recruitment of CSK is required for its potency. Thus, the two major activities known to repress TCR phosphorylation in T cells are sufficient, when combined, to keep the TCR in a quiescent state in this reconstituted cell system. ZAP70 is normally cytosolic but binds to phosphorylated TCR ITAMs. The translocation of ZAP70-green fluorescent protein (GFP) from the cytosol to the plasma membrane therefore provides a microscopy-based assay of TCR triggering. Indeed, Lck expression in HEK-1G4 cells caused ZAP70-GFP to accumulate at the plasma membrane ( Fig. 1d, e ), whereas co-expression of CSK, CBP and CD45 delocalized ZAP70 to the cytoplasm (Fig. 1e ). Furthermore, ZAP70-GFP translocated rapidly to the plasma membrane upon CD45 phosphatase inhibition by pervanadate ( Fig. 1f and Supplementary Movie 1). Thus, this visual assay provides a dynamic readout of TCR triggering.
Reconstitution of a T cell-APC conjugate
Having identified a minimal set of components that could be expressed in HEK-1G4 cells to mimic the basal or 'off' state of their T-cell counterpart, we next attempted to trigger signalling by having the 1G4 TCR interact with its ligand, the MHC class-I complex bound with a short peptide (ESO9V) (ref. 19 ) and expressed in the Raji B-cell line as the APC ( Fig. 2a and Supplementary Methods). Because HEKs and Raji B cells have no intrinsic affinity for each other (Supplementary Fig. 3a ), we expressed the immune-cell adhesion proteins CD2 and ICAM1 on the HEK-1G4 cells ( Fig. 2a ), which can interact with their respective counter-receptors CD58 and LFA-1 expressed endogenously on Raji cells ( Supplementary Fig. 1 ). This strongly increased the conjugation between the two cell types, with the LFA-1-ICAM1 interaction being the predominant driver (Supplementary Fig. 3a ). 
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We found that the HEK-1G4 cells formed a cup-shaped contact around the APC expressing antigenic pMHC (Supplementary Movie 2), which was notably similar to T cell-APC conjugates 20 . pMHC was concentrated at the site of cell-cell interaction (Fig. 2b, c) , and importantly, ZAP70 in the HEK-1G4 cells translocated to the plasma membrane in this region, showing that TCR triggering had occurred ( Fig. 2b-d ; confirmed by immunoblotting in Supplementary  Fig. 2b ). Triggering was rapid and could be observed within 1 min of cell contact (Supplementary Movie 3). Membrane translocation of ZAP70 did not occur when HEK-1G4 cells were conjugated with Raji cells expressing a control peptide-MHC complex (Fig. 2b, d ) or in HEK-1G4 cells lacking transfected Lck ( Fig. 2d and Supplementary Fig. 2b ). We also found that the ITAMs of CD3f were sufficient for ligandspecific ZAP70 translocation by using a minimal TCR complex with the intracellular sequences of CD3c, d and e truncated after the transmembrane domain (TCR Ex f Int , where 'Ex' denotes the extracellular and transmembrane parts of the molecule and 'Int' denotes the intracellular part; Fig. 2d ). Although the APC used in these experiments expressed the cognate pMHC at high levels (,50 pMHC per mm 2 ), ZAP70 recruitment was still observable at lower, more physiological, levels of antigenic pMHC (,3 pMHC per mm 2 ) (refs 21, 22) ( Supplementary Figs 1 and 4 ). In summary, an APC expressing the appropriate pMHC is able to elicit a specific TCR-triggering response from our reconstituted HEK-1G4 cell.
Disrupting the actin cytoskeleton severely inhibits T-cell activation 23 , but its role in TCR triggering is uncertain. Depolymerization of actin filaments in HEK-1G4 cells before mixing with APCs significantly decreased the number of conjugates ( Supplementary Fig. 3b ), but cells that did interact still showed ZAP70 recruitment (Supplementary Fig. 3c ). This result indicates that the cytoskeleton facilitates the initial cell-cell interactions but is not essential for TCR triggering in this reconstituted cell system.
Mechanistic insight into how the TCR was triggered by pMHC came from the observation that CD45 phosphatase was excluded from the cell-cell interface where the TCR was bound to its cognate ligand ( Fig. 2b, c) , whereas Lck remained included ( Supplementary Fig. 5a ). As complete repression of Lck phosphorylation of the TCR required CD45, CSK and CBP (Fig. 1c ), the segregation of CD45 away from the TCR would be predicted to shift the steady-state balance towards TCR phosphorylation. Previous studies have also found that most CD45 molecules are excluded from the interface of real T cell-APC conjugates 24, 25 and could be involved in triggering 26, 27 . However, it has been difficult to ascertain whether CD45 exclusion is responsible for, or a consequence of, TCR triggering. To show more definitively that CD45 exclusion has a causal role, we redirected phosphatase activity into the cell-cell interface by fusing the intracellular phosphatase domains of CD45 to the extracellular and transmembrane domains of CD2 (termed CD2 Ex CD45 Int ), because CD2 was localized within the conjugate interface ( Supplementary Fig. 5b ). The CD2 Ex CD45 Int construct was observed clearly within the interface, as expected ( Fig. 2e) , and ZAP70 was no longer recruited to this region, indicating that TCR triggering was abolished ( Fig. 2d, e ). This result shows that CD45 exclusion is required for TCR triggering in our reconstituted cell system.
To show that CD45 exclusion and TCR triggering were not dependent on each other, we temporally separated the formation of the signalling zone from TCR triggering by engineering a TCR lacking its ITAMs but instead having an intracellular recruitment domain (FKBP) (TCR Ex FKBP Int ; Fig. 3a ). We expected this receptor to localize within the cell-cell interface through its extracellular interaction with pMHC, but to be unable to recruit ZAP70 in the absence of any signalling motifs. To initiate TCR phosphorylation and ZAP70 recruitment, an FKBP-binding domain (FRB) was fused to the cytoplasmic region of CD3f (FRB-CD3f Int ), which can be induced to dimerize with TCR Ex FKBP Int upon addition of the drug rapamycin (Fig. 3a ). CD45 and pMHC were excluded and concentrated from the conjugate interface, respectively, in the absence of rapamycin. However, ZAP70 was recruited to the membrane in the zones of CD45 exclusion only when the separated components of the TCR (TCR Ex FKBP Int and FRB-CD3f Int ) were brought together with rapamycin (Fig. 3b, c) . Time-lapse imaging showed no discernible delay between the translocation of FRB-CD3f Int to the plasma membrane and the subsequent recruitment of ZAP70 ( Fig. 3d and Supplementary Movie 4).
The mechanism of CD45 segregation
We next wished to explore what forces produce CD45 exclusion. MHC bound with a control peptide did not elicit CD45 segregation (Fig. 2b) , therefore the adhesion pairs (CD2-CD58 and LFA-1-ICAM1) must be incapable of driving exclusion ( Supplementary Fig. 5c ). We next tested the TCR-pMHC interaction alone, and found that it was sufficient for conjugation ( Supplementary Fig. 3a ) and CD45 segregation (Fig. 4a ). Fluorescence recovery after photobleaching (FRAP) and fluorescence loss in photobleaching (FLIP) experiments showed that the TCR remained mobile after pMHC binding and free to escape the conjugated region, showing that the segregated zone was not formed by an immobile aggregate and remained contiguous with the rest of the cell surface ( Supplementary Fig. 6 ). Thus, the TCR-pMHC interaction 
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is necessary and sufficient for CD45 exclusion, with no requirement for downstream TCR triggering/signalling. Next, we examined how the TCR-pMHC interaction affected the spacing of the two plasma membranes of the interacting cells. Using a subdiffraction-resolution method, we measured the separation between a GFP-tagged TCR in the HEK cells and mCherry-pMHC in the APC ( Fig. 4b and Supplementary Methods). The measured distance of ,31 nm (Fig. 4b) suggests a cell-cell separation of ,15 nm, which agrees well with the 13 nm cell-to-cell distance between T cells and conjugated APCs measured by electron microscopy (ref. 28) . By contrast, the membrane separation for Raji cells expressing control pMHC conjugated through adhesion molecules alone (ICAM1-LFA-1 or ICAM1-LFA-1 and CD2-CD58) was much greater (Fig. 4b) . These results show that the TCR-pMHC interaction brings the membranes much closer together than occurs with the adhesion molecules.
Proteins with extended extracellular domains (such as CD45) might be prevented from entering regions of close membrane apposition, as suggested by the kinetic-segregation model 8 . We tested this hypothesis by fusing the intracellular phosphatase domains of CD45 to an extracellular domain (from CD86) of comparable size to the TCR (termed CD86 Ex CD45 Int ). CD86 Ex CD45 Int was also excluded from the cell-cell interface, although its exclusion ( Fig. 4c ) and TCR triggering ( Supplementary Fig. 7a, b) were somewhat lower than that seen with the large CD45 construct (Fig. 4c ). Because of this unanticipated exclusion of a protein with a small extracellular domain, we next tested mCherry fusion proteins of a series of membrane proteins with different properties: CD58, a transmembrane protein with an equivalently sized extracellular domain to CD86; b 2 -adrenergic receptor (b 2 AR, also known as ADRB2), a seventransmembrane protein with small extracellular loops; and a prenylated version of the fluorophore linked to the inner leaflet of the bilayer by using a short targeting sequence (CAAX) (Fig. 4c ). CD58 was excluded to a similar level as CD86 Ex CD45 Int , showing that the segregation of the latter construct was not due to the intracellular phosphatase domains of CD45 (Fig. 4c) . b 2 AR, a protein with a large lateral footprint, was also partially excluded (Fig. 4c ), possibly through a crowding effect arising from the high density of pMHC-TCR in the conjugate region. However, the prenylated mCherry was distributed evenly throughout the cell membrane, showing no exclusion by TCR-pMHC (Fig. 4c) .
The above experiments cannot explain why CD2 ( Supplementary  Fig. 5b ) and CD2 Ex CD45 Int (Fig. 2e ), which has extracellular domains similar in size to CD86, were not excluded from the cell-cell contact zone. We speculated that binding of CD2 to its ligand (CD58) expressed endogenously on the APC provided a counteracting force to constrain CD2 within the conjugate region. If this were true, then expressing CD28, the binding partner for CD86, on the APC should diminish the TCR-pMHC-mediated segregation of CD86 Ex CD45 Int . Indeed, when CD86 Ex CD45 Int -expressing HEK-1G4 cells were conjugated with APCs co-expressing CD28, CD86 Ex CD45 Int localized at the cell-cell interface and TCR triggering was greatly decreased ( Supplementary Fig. 7b, c) .
In summary, the TCR-pMHC interaction alone is capable of excluding plasma membrane proteins with extracellular extensions and that exclusion can be overcome by the energy provided by binding to a protein partner on the APC.
Triggering of artificial receptors
The preceding experiments suggested that TCR triggering results from CD45 segregation, which is driven by the binding interaction between the TCR and pMHC. If this is true, then interactions between extracellular domains of membrane proteins with the proper spacing and affinity might elicit comparable effects to TCR-pMHC, as has been shown in T cells 28 . To explore this idea, we engineered a chemically controlled, cell-surface-receptor system consisting of a transmembrane protein with extracellular FKBP and the intracellular CD3f ITAM domains expressed in the HEK cell (FKBP Ex f Int ; mimicking the TCR) and a transmembrane protein with an extracellular FRB expressed in the APC (mimicking the pMHC) ( Fig. 5a) . FKBP Ex f Int and FRB Ex will only interact in the presence of rapamycin, forming a complex that spans a similar distance to TCR-pMHC. In the absence of rapamycin, conjugates formed (through the LFA-1-ICAM1 interaction) but ZAP70 was not recruited to the membrane (Fig. 5b, c) . However, with rapamycin, FKBP Ex f Int receptor clusters were observed at the cell-cell interface, even with low levels of FRB Ex ligand that are equivalent to physiological densities of antigen pMHC (,5 molecules per mm 2 ; Supplementary Fig. 1 ). Furthermore, CD45 was excluded from and ZAP70 was recruited to these receptor clusters, indicating that triggering had occurred ( Fig. 5b-d) .
Our artificial receptor is structurally analogous to chimaeric antigen receptors (CARs), which have an extracellular single-chain antibody fragment fused to a transmembrane sequence and cytoplasmic CD3f ITAMs. When the CD19-specific CAR (ref. 29 ), which has 
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shown promise in recent clinical trials as a gene therapy treatment of leukaemia 29 , was expressed in our reconstituted HEK cells and these cells were conjugated with Raji B cells (which are CD19 1 ), we observed CAR clustering, ZAP70 recruitment and CD45 exclusion (Fig. 5e, f) . This triggering was ligand specific, as conjugation with CD19 2 cells did not produce these effects (Fig. 5e, f) . Interestingly, the interface of many CD192CAR HEK cell and CD19 1 Raji B-cell conjugates showed a highly convoluted membrane surface (Supplementary Movie 5), which was not seen for cells interacting through either TCR-pMHC or FKBP Ex f Int 2FRB Ex . This membrane effect could be a product of high-affinity antibody binding and might warrant further investigation for its relevance to CAR potency or potential side effects.
Conclusion
Our reconstitution experiments show a physical mechanism for TCR triggering that differs from dimerization or conformational-change models proposed for many cell-surface receptors. We find that the binding energy of the TCR-pMHC interaction generates an exclusion force for membrane proteins with large and/or unligated extracellular domains, even in the absence of downstream signalling. By linking an inhibitory phosphatase activity to a transmembrane protein (CD45) that is subject to the exclusion force and an activating kinase (Lck) to the inner leaflet of the membrane that is not, the TCR-pMHC interaction can shift the kinase-phosphatase balance and thus trigger the TCR, as first suggested by the kinetic-segregation model 8 . Because the FKBP-rapamycin-FRB or antibody-antigen modules can replace the extracellular TCR-pMHC interaction, conformational changes in the TCR are unlikely to be critical for the fundamental mechanism of triggering. Co-receptors and actin also do not seem to be essential for transducing TCR-pMHC binding across the plasma membrane, although it is very probable that they are necessary for achieving the high sensitivity and full selectivity of T-cell activation. This could be tested in the future by pushing our reconstituted system to respond to very low antigen densities using more sensitive read-outs of triggering. The precise mechanism by which the TCR-pMHC interaction results in protein exclusion remains elusive, although our data provide certain clues. Exclusion according to the kinetic-segregation model is based on the greater size of the extracellular domain of CD45 compared to the TCR-pMHC complex. However, although size influences the extent of exclusion, our data show that membrane proteins with small extracellular domains are also excluded, suggesting that additional forces must be acting on the system. We speculate upon the driving force in the following model, which incorporates previous findings [30] [31] [32] [33] [34] . Within the initial adhesion mediated by LFA-1-ICAM1 between the T cell and APC, transient fluctuations bring the two membranes in closer apposition, allowing TCR and pMHC molecules to interact (Fig. 6a) . The binding energy of this interaction must be sufficient to overcome unfavourable membrane bending and compression of the large proteins that constitute the 
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glycocalyx, such as CD45, which occur when the two membranes regions are brought close together (Fig. 6b) . In a critical next step, separate regions of close membrane apposition consolidate passively into larger, contiguous regions, resulting in a net decrease in membrane bending, as has been previously suggested 35 . Proteins that do not provide any binding energy will be excluded over time, because, as they diffuse from the region, interacting molecules will be further clustered as the area of close apposition is minimized (Fig. 6c ). These same principles may explain how TCR microdomains initiate when T cells interact with pMHC on a supported lipid bilayer [36] [37] [38] (note the small exclusion zones in our experiments at low ligand densities ( Fig. 5d and Supplementary Fig. 4) ).
Overall, our data suggest how the binding energy associated with specific molecular recognition events that take place between two interacting cells can be transduced into intracellular biochemical reactions that change cell behaviour. This model provides a plausible mechanism to explain how CARs trigger T cells to kill cancerous cells 29 and may apply to other cell types that signal using membranebound receptors and ligands.
METHODS SUMMARY
Multiple proteins were expressed in HEK cells using a combination of transient and stable expression by lentiviral transduction; proteins were expressed at close to physiological levels and in the correct localization as described in Supplementary Methods. To create cell conjugates, the two cell types were centrifuged, resuspended at high density and placed on glass-bottomed dishes for live-cell imaging at 37 uC using spinning disc confocal microscopy. Image analysis, including the intermembrane distance algorithm, was performed using ImageJ and Matlab (Supplementary Methods). Full methods and supplementary material accompany this paper.
